The Short Version
- Agentic AI in healthcare is moving from early adopters to early majority, but the chasm between "pilot" and "production" remains wide
- The organizations crossing successfully share operational maturity, not technological sophistication
- The differentiator is infrastructure and governance readiness, not model selection or vendor choice
What Happened
March 2026 marks an inflection point. Three signals that agentic AI is crossing the chasm in healthcare:
Signal 1: Payer adoption. UnitedHealthcare, Humana, and Centene all disclosed AI agent deployments in their Q4 2025 earnings calls. Not pilots. Production systems handling claims adjudication, member engagement, and provider credentialing. When payers deploy, the entire ecosystem shifts.
Signal 2: EHR vendor integration. Epic, Oracle Health (Cerner), and Athenahealth all announced native agentic AI features in their spring releases. This is not third-party bolt-on. This is embedded in the workflow. When the EHR vendor ships it as a feature, the adoption curve steepens.
Signal 3: Regulatory engagement. CMS published draft guidance on "AI-assisted care management" reimbursement. ONC updated the TEFCA framework to address AI agent data access. When regulators start writing rules, the technology is past experimental.
What It Likely Means
Geoffrey Moore's "Crossing the Chasm" framework applies here with uncomfortable precision.
Early adopters (2024-2025) were large academic medical centers and well-funded health systems with dedicated AI teams. They had the resources to experiment, the tolerance for failure, and the internal expertise to manage novel technology.
The chasm is the gap between those early adopters and the early majority: community hospitals, regional health systems, multi-site physician groups, and specialty practices that do not have dedicated AI teams, cannot afford to fail, and need technology that works within their existing operational constraints.
Crossing the chasm requires a different value proposition. Early adopters bought innovation. The early majority buys operational improvement with manageable risk.
That is why the EHR vendor integration matters so much. A community hospital is not going to hire an ML engineering team and build custom AI agents. But they will turn on a feature in their existing Epic or Athenahealth instance if it comes with documentation, training, and support.
What the Market Might Be Missing
1. The chasm is operational, not technical. The AI models are ready. The cloud infrastructure is ready. The APIs are ready. What is not ready: the workflow documentation, data normalization, governance policies, and change management capacity at most healthcare organizations. You cannot deploy an autonomous scheduling agent if your scheduling rules exist only in the heads of your front desk staff.
2. The early majority has different buying criteria. Early adopters evaluated AI on capability: "What can this model do?" The early majority evaluates on risk: "What happens when it fails?" Vendors that cannot answer the failure question with specifics (rollback procedures, audit trails, liability allocation) will not sell to the early majority.
3. Consolidation is coming. The current market has over 200 healthcare AI startups. The early majority does not want 200 options. They want 3-5 proven solutions with EHR integration, regulatory compliance, and referenceable deployments. Within 18 months, expect significant M&A as the market consolidates around the platforms that cracked the integration and governance problems.
The Pharmacy Parallel
When automated dispensing machines crossed the chasm in pharmacy, the winners were not the companies with the most advanced robotics. They were the companies that solved the workflow integration problem: connecting to pharmacy management systems, handling exceptions gracefully, and providing audit trails that satisfied state pharmacy boards.
Same dynamic here. The AI agent vendors that will win the early majority are not the ones with the best models. They are the ones that solve the integration, governance, and rollback problems in ways that work for organizations without dedicated AI teams.
The Bottom Line
- Assess organizational readiness before vendor readiness. Can your team document their workflows in enough detail to hand them to a new employee on day one? Do you have a data governance policy that predates your AI strategy? Was your compliance team involved before the vendor was selected? If the answer to any of these is no, you are not ready for agentic AI. You are ready for a readiness assessment.
- Buy from vendors who have crossed the chasm themselves. Referenceable production deployments at organizations similar to yours. Not pilot programs. Not "design partners." Production. With measurable outcomes. If the vendor cannot provide three references who will talk candidly about their deployment experience, move on.
- Plan for the 18-month consolidation. Do not lock into a startup vendor without an exit strategy. Use standard interfaces, insist on data portability, and negotiate contract terms that protect you if the vendor is acquired or pivots. The AI vendor landscape will look very different by 2028.